MedPath

Effect of Prophylactic Administration of Oxytocin in Uniject™ on Postpartum Hemorrhage at Home Births in Ghana

Not Applicable
Completed
Conditions
Postpartum Hemorrhage
Interventions
Other: Oxytocin in Uniject
Registration Number
NCT01108289
Lead Sponsor
Johns Hopkins Bloomberg School of Public Health
Brief Summary

This study is designed to test the hypothesis that the intramuscular administration of 10 IU of oxytocin in Uniject™ during the third stage of labor by a Community Health Officer (CHO) at home births in Ghana will reduce the risk of postpartum hemorrhage by 50 percent relative to home births attended by the same type of provider who does not provide a uterotonic drug.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1586
Inclusion Criteria
  • home delivery
  • presence of Community Health Officer at time of delivery
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Oxytocin in UnijectOxytocin in UnijectCommunity Health Officers will provide 10 IU Oxytocin in Uniject device IM immediately after delivery of baby
Primary Outcome Measures
NameTimeMethod
postpartum hemorrhage-1after delivery of baby

blood loss \>=500 ml after delivery of the baby, as measured through plastic calibrated drape

postpartum hemorrhage-2after delivery of the baby

blood loss \>=500ml OR treatment dose of oxytocin provided

postpartum hemorrhage-3after delivery of the baby

blood loss \>=500ml OR treatment dose of oxytocin provided OR referral for bleeding

Secondary Outcome Measures
NameTimeMethod
Oxytocin use before deliverylabor and delivery

the proportion of deliveries where oxytocin in uniject was administered prior to the delivery of the baby

stillbirthlabor/delivery

stillbirth is defined as death of a fetus after 28 weeks of gestation, prior to birth

neonatal deathfirst month of life

neonatal death is defined as death of a live born baby prior to completion of 28 days

need for neonatal resuscitation0-6 hours after birth

Trial Locations

Locations (1)

Kintampo Health Research Center

🇬🇭

Kintampo, Brong Ahafo, Ghana

© Copyright 2025. All Rights Reserved by MedPath